Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 3160-91-6 | MDL No. : | MFCD00012798 |
Formula : | C6H14ClN5O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | FXYZDFSNBBOHTA-UHFFFAOYSA-N |
M.W : | 207.66 | Pubchem ID : | 76621 |
Synonyms : |
ABOB hydrochloride;Moroxydine (hydrochloride);ABOB, Bimolin, Moroxydine free base, SKF 8898-A, SKF 8898A, Virugon, Virumin, Wirumin;ABOB;Moroxydine hydrochloride
|
Chemical Name : | N-Carbamimidoylmorpholine-4-carboximidamide hydrochloride |
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.67 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 4.0 |
Molar Refractivity : | 56.39 |
TPSA : | 98.22 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -8.01 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | -0.63 |
Log Po/w (WLOGP) : | -0.84 |
Log Po/w (MLOGP) : | -0.62 |
Log Po/w (SILICOS-IT) : | -1.12 |
Consensus Log Po/w : | -0.64 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.53 |
Solubility : | 60.9 mg/ml ; 0.293 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.96 |
Solubility : | 22.8 mg/ml ; 0.11 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | 0.06 |
Solubility : | 238.0 mg/ml ; 1.15 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.68 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
5.2 kg | With sulfuric acid; ammonium chloride In water at 120℃; for 1 h; Sealed tube; Large scale | (1) to the 10L in the reactor with mechanical stirrer are sequentially added diethylene glycol 2.1 kg, dicy 2.0 kg, ammonium chloride 1.4 kg, quality quality concentration is 30percent sulfuric acid aqueous solution of 0.5 kg, the seal under stirring, every minutes to 3 degrees centigrade to the temperature increase speed of 120 °C, reactor pressure to rise to 0.3 MPa, reaction 1 hour later, natural cooling the reaction temperature to the room temperature, to obtain white milk;(2) the white cream is transferred to the 50L in glass autoclave, add 95percent ethanol 15 kg, heating reflux reaction 30 minutes to get mixed solution, the mixed fluid after filter drum heat filter in the crystallization kettle, the filtrate is cooled to room temperature in the crystallization kettle, separating white crystal, after centrifugal separation, the 80 °C after hot blast oven drying and under the conditions can be obtained trunk guanidine morpholine hydrochloride 5.2 kg, to dicy the idea receives rate to 81percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
17 kg | Stage #1: at 140℃; for 3 h; Large scale Stage #2: for 0.5 h; Reflux; Large scale |
(3) The comparative experimental procedure (2) obtained in step morpholine hydrochloride was added to the 100L glass reactor, weighed 15Kg dicyandiamide was added to the reactor, the stirring reactor was heated to 140 , reactant in the molten state, the reaction was stirred for 3 hours, heating was stopped, cooled to room temperature.(4) The 40Kg95percent ethanol into a reactor, heated to reflux and stirred for 30 minutes, filtered hot and cooled to crystallize kettle crystallized white solid after centrifugation, oven dried by hot air to give a white morpholino amidine guanidine hydrochloride 17.0Kg ( morpholine total income was 48percent, in order to gauge their dicyandiamide 46percent yield). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
17 kg | (3) The comparative experimental procedure (2) obtained in step morpholine hydrochloride was added to the 100L glass reactor, weighed 15Kg dicyandiamide was added to the reactor, the stirring reactor was heated to 140 , reactant in the molten state, the reaction was stirred for 3 hours, heating was stopped, cooled to room temperature.(4) The 40Kg95percent ethanol into a reactor, heated to reflux and stirred for 30 minutes, filtered hot and cooled to crystallize kettle crystallized white solid after centrifugation, oven dried by hot air to give a white morpholino amidine guanidine hydrochloride 17.0Kg ( morpholine total income was 48percent, in order to gauge their dicyandiamide 46percent yield). | |
In butan-1-ol; at 90 - 123℃; for 8h; | General procedure: Cyanoguanidine (dicyandiamide) (2.86 g, 34 mmol) was added to an appropriate solution of aminehydrochloride (34 mmol) in anhydrous n-butanol (10 mL). The mixture was carefully heated until theexothermic reaction was initiated (ca. 90 C) before being stirred at 122?123 C for 8 h. After cooling,the mixture was stirred for a further 6 h at room temperature. The next day, the precipitate was filtered,washed with n-butanol and isopropanol and purified by crystallization using methanol. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
79.5% | In butan-1-ol; for 15h;Reflux; | General procedure: Example 108: Synthesis of N1-methyl biguanide hydrochloride (0246) (0247) Methylamine hydrochloride (1.3 g, 19.84 mmol) was dissolved in n-butanol (30 mL) at room temperature. Cyanoguanidine (1.68 g, 19.98 mmol) was added thereto and the mixture was stirred under reflux for 15 hours. The reaction mixture was concentrated under reduced pressure, and separated and purified using a chromatography in a condition where the ratio of methylene chloride to methyl alcohol was 9:1 and the target compound was obtained as a white solid (0.90 g, 61.0percent). 1H NMR (600 MHz, DMSO) delta2.86 (s, 3H) LCMS: 116.1 [M+H]+ |
EXAMPLE 11 Synthesis of Moroxydine Amidinothiourea (2.36 g, 0.02 m) was suspended in 5 ml of water. Sodium molybdate dihydrate (0.012 g, 0.0005 m) and about 1.5 g of sodium chloride were added. The solution was cooled to 0° C. and 30percent hydrogen peroxide (8.4 ml, 0.08 m) was added dropwise: addition of the first 2.5 ml was very exothermic, dropwise addition required about 45 min. After addition of the second eq, the reaction mixture was allowed to warm to 14°-16° C., at which point the mixture exothermed to 50°-60° C. After cooling to 5° C., the third eq of peroxide was added dropwise; no exotherm was noted. Further cooling afforded a precipitate which was air dried and then placed under high vacuum to give 1.4 g, mp 158°-170° C. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
85% | (1) salt formation reaction, adding morpholine to the reactor, stirring and bringing the temperature to 29 C, and then adding concentrated hydrochloric acid;When the pH value in the reactor is 1 to 2 and is constant, the dropwise addition is stopped. After the reaction is completed, the water is concentrated in a vacuum to obtain morpholine hydrochloride having a water content of 5% or less; morpholine and concentrated hydrochloric acid are obtained. The molar ratio is 1:1.15;(2) addition reaction, adding isoamyl alcohol and dicyandiamide to the above morpholine hydrochloride, and increasing the temperature to 135 C to start the addition reaction; after the reaction starts, the reactor is first dissolved, then turbid, turbid After the reaction was continued for 3 h, the reaction was completed; then it was cooled to room temperature, stirred for 0.5 h, filtered, and the filter cake was washed with isoamyl alcohol, and dried to obtain a crude morpholine hydrochloride having a morpholine yield of 95%; morpholine and double The molar ratio of cyanamide is 1:1.15;(3) Purification, referring to Example 1, a morpholinium hydrochloride fine product having a morpholine yield of 85% was obtained. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93% | In tetrahydrofuran; at 70℃; for 0.333333h;Microwave irradiation; | General procedure: A mixture of sodium methoxide (1.5 mmol) prepared from Na and methanol, arylbiguanide hydrochloride (1 mmol) 1 and ester (3 mmol) in dry THF (5 mL) was introduced into a round-bottomed flask equipped with a condenser and a magnetic stirring bar. The flask was placed in the microwave cavity and exposed to microwave irradiation for 20 min at 70 C using irradiation power of 100W. On cooling to room temperature, the mixture was evaporated under vacuum, and the residue was subjected to flash chromatography (silica gel, 5percent methanol/CH2Cl2) to afford the desired product as a white solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
72.5% | In tetrahydrofuran; at 70℃; for 0.333333h;Microwave irradiation; | General procedure: A mixture of sodium methoxide (1.5 mmol) prepared from Na and methanol, arylbiguanide hydrochloride (1 mmol) 1 and ester (3 mmol) in dry THF (5 mL) was introduced into a round-bottomed flask equipped with a condenser and a magnetic stirring bar. The flask was placed in the microwave cavity and exposed to microwave irradiation for 20 min at 70 C using irradiation power of 100W. On cooling to room temperature, the mixture was evaporated under vacuum, and the residue was subjected to flash chromatography (silica gel, 5percent methanol/CH2Cl2) to afford the desired product as a white solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | In tetrahydrofuran; at 70℃; for 0.333333h;Microwave irradiation; | General procedure: A mixture of sodium methoxide (1.5 mmol) prepared from Na and methanol, arylbiguanide hydrochloride (1 mmol) 1 and ester (3 mmol) in dry THF (5 mL) was introduced into a round-bottomed flask equipped with a condenser and a magnetic stirring bar. The flask was placed in the microwave cavity and exposed to microwave irradiation for 20 min at 70 C using irradiation power of 100W. On cooling to room temperature, the mixture was evaporated under vacuum, and the residue was subjected to flash chromatography (silica gel, 5percent methanol/CH2Cl2) to afford the desired product as a white solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
98% | In tetrahydrofuran; at 70℃; for 0.333333h;Microwave irradiation; | General procedure: A mixture of sodium methoxide (1.5 mmol) prepared from Na and methanol, arylbiguanide hydrochloride (1 mmol) 1 and ester (3 mmol) in dry THF (5 mL) was introduced into a round-bottomed flask equipped with a condenser and a magnetic stirring bar. The flask was placed in the microwave cavity and exposed to microwave irradiation for 20 min at 70 C using irradiation power of 100W. On cooling to room temperature, the mixture was evaporated under vacuum, and the residue was subjected to flash chromatography (silica gel, 5percent methanol/CH2Cl2) to afford the desired product as a white solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
43% | With copper(l) iodide; glycine; In 1,4-dioxane; at 110℃; for 13h; | biguanide hydrochloride was added in a reaction vessel, piperidine (0 ·2057g), 1,1-dibromo (3,4-dimethoxyphenyl) styrene (0 · 1286g), cuprous iodide (0 · 0076g), 2, 2'- dipyridyl (0 · 0125g), potassium (0 · 5094g) phosphate, mixed at 110 °C in oil bath and stirred in 1,4-dioxane (5mL) for 13 hours; the reaction after filtration, the filter residue washed with methanol, the filtrate was concentrated by column chromatography (dichloromethane: methanol = 50: 1), R f value of 0.3 were collected ~ 035 eluate by distillation under reduced pressure, and dried to give. the target compound III-I (billion. l67g, yield 81percent).The procedure described in Example 1, except that piperidine hydrochloride was replaced with biguanide N, N, Nu ', Nu' - tetramethyl-biguanide hydrochloride (0. 1937g, 1.0 Ommol), 2, 2 '- bipyridine to glycine (0. 0060g, 0. 08mmol), to obtain the objective compound II1-5 (0 · 0546g, 43percent yield).[0051] 1H NMR (500MHz, CDCl3): delta 7. 07 (d, J = 1. 8Hz, 1H), 6. 94 (dd, J = 8. I, I. 8Hz, 1H), 6. 79 ( d, J = 8. 1Hz, 1H), 3. 88 (s, 3H), 3. 86 (s, 3H), 3. 76 (s, 2H), 3. 13 (s, I 2H) square |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
5.2 kg | With sulfuric acid; ammonium chloride; In water; at 120℃; under 2250.23 Torr; for 1h;Sealed tube; Large scale; | (1) to the 10L in the reactor with mechanical stirrer are sequentially added diethylene glycol 2.1 kg, dicy 2.0 kg, ammonium chloride 1.4 kg, quality quality concentration is 30percent sulfuric acid aqueous solution of 0.5 kg, the seal under stirring, every minutes to 3 degrees centigrade to the temperature increase speed of 120 °C, reactor pressure to rise to 0.3 MPa, reaction 1 hour later, natural cooling the reaction temperature to the room temperature, to obtain white milk;(2) the white cream is transferred to the 50L in glass autoclave, add 95percent ethanol 15 kg, heating reflux reaction 30 minutes to get mixed solution, the mixed fluid after filter drum heat filter in the crystallization kettle, the filtrate is cooled to room temperature in the crystallization kettle, separating white crystal, after centrifugal separation, the 80 °C after hot blast oven drying and under the conditions can be obtained trunk guanidine morpholine hydrochloride 5.2 kg, to dicy the idea receives rate to 81percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78% | With [2,2]bipyridinyl; copper(l) iodide; In 1,4-dioxane; at 110℃; for 13h; | To the reaction vessel was added morpholine biguanide hydrochloride (0.2077 g), 1,1-dibromo-styrene (0.1048 g), cuprous iodide(0.0076 g), 2,2'-bipyridine (0.0125 g) and potassium phosphate (0.5094 g) were mixed in 1,4-dioxane (5 mL)And the mixture was stirred for 13 hours in a bath. After completion of the reaction, the reaction mixture was filtered and the residue was washed with methanol. The filtrate was concentrated and purified by column chromatography (dichloromethane:Methanol = 50: 1), collecting Rf value of 0.3 ~ 0.35 of the eluent, vacuum distillation and drying to obtain the target compound (I), the amount of 0.0847g,The yield was 78percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
58% | With acetic acid;Reflux; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride or Metformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120 oCfor 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | With acetic acid;Reflux; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride or Metformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120 oCfor 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
72% | With acetic acid;Reflux; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride or Metformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120 oCfor 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | With acetic acid;Reflux; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride or Metformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120 oCfor 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | With acetic acid;Reflux; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride or Metformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120 oCfor 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
68% | With acetic acid;Reflux; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride or Metformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120 oCfor 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
72% | With acetic acid;Reflux; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride or Metformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120 oCfor 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
63% | With acetic acid;Reflux; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride or Metformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120 oCfor 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | With acetic acid;Reflux; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride or Metformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120 oCfor 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | With acetic acid;Reflux; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride or Metformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120 oCfor 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
58% | With acetic acid;Reflux; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride or Metformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120 oCfor 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
55% | With acetic acid;Reflux; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride or Metformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120 oCfor 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
63% | With acetic acid;Reflux; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride or Metformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120 oCfor 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | With acetic acid;Reflux; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride or Metformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120 oCfor 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
58% | With acetic acid;Reflux; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride or Metformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120 oCfor 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
63% | With acetic acid;Reflux; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride or Metformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120 oCfor 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
52% | With acetic acid;Reflux; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride or Metformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120 oCfor 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With potassium carbonate; In water; at 20℃; for 0.5h; | The synthetic route is shown in Figure 1.In a 25 mL single port round bottom flask,In order to add 2.1g (10mM)N- (2- guanidino - ethyl imino) - morpholine hydrochloride,10mL distilled water,Stir to dissolve the solid,Add 1.6g (12mM) potassium carbonate,Magnetic stirring at room temperature for 30 minutes,The water phase is evaporated under reduced pressure,A white solid powder is obtained,Dissolve the solid powder with methanol,The resulting potassium chloride and excess potassium carbonate were removed by filtration and the filtrate was evaporated to dryness to afford N-(2-mercapto-ethylimino)-morpholine a.Then in a 25 ml single-mouth round bottom flask,342.4 mg (2 mM) of N-(2-mercapto-ethylimino)-morpholine a was added successively.162.1 mg (3 mM) sodium methoxide and 444.5 mg (6 mM) ethyl formate,Then add 12ml THF,The reaction was stirred at 60 °C for 36 h during which time it was monitored by TLC. Evaporate the solventThe crude product was isolated and purified by column chromatography (MeOH:TCM=1:10) to give the hapten Ia. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
The synthetic route is shown in Figure 1.0.4 g (7.0 mM) sodium methoxide with 1.0 g (4.8 mM)N-(2-mercapto-ethylimino)-morpholine hydrochloride was placed in a 50 mL single-mouth round bottom flask.Add an appropriate amount of anhydrous THF and stir at room temperature.A mixed solution of 1.2 g (14.0 mM) of ethyl acetate and 10 ml of dry THF was slowly added dropwise with stirring.After dropping,Condensate reflux at 80°C for 36 h during which time it was monitored by TLC.After the reaction is over,Evaporate the solventThe crude product was isolated and purified by column chromatography (MeOH:TCM=1:10).Haploid Ib. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
48% | In methanol; at 20 - 22℃; for 2h; | Ethyl cyanoacetate (3.46 g, 3.44 mL, 30.57 mmol, d = 1.418 g/mL) was added dropwise to a solutionof N-carbamimidoylmorpholine-4-carboximidamide (5.23 g, 30.57 mmol) in anhydrous methanol(48 mL) over 1 h. The mixture was stirred for 2 h at room temperature (20?22 C). The precipitate wasfiltered and washed with cold methanol (5 C). The product was crystallized from methanol. Yield3.2 g (48percent); m.p. 164?165 C (MeOH), reference [66]: 178?180 C; IR (KBr) max (cm1): 3352, 3315,3202, 2974, 2951, 2258, 1650, 1574, 1530, 1471, 1447, 1380, 1335, 1152, 969, 808, 631; 1H-NMR (200 MHz,DMSO-d6) (ppm): 3.55?3.63 (m, 4H, 2xCH2), 3.64?3.75 (m, 4H, 2xCH2); 3.88 (s, 2H, CH2), 7.04 (s, 1H,NH), 7.12 (s, 1H, NH). Anal. calcd. for C9H12N6O (220.23): C, 49.08; H, 5.49; N, 38.16. Found: C, 49.02;H, 5.41; N, 38.18. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
67% | With tris(triphenylphosphine)ruthenium(II) chloride; potassium tert-butylate; In 1,4-dioxane; at 120℃; for 22h; | To the reaction vessel was added Moroxydine hydrochloride(103.8 mg, 0.50 mmol), cinnamyl alcohol (67.2 mg, 0.50 mmol),Tris(triphenylphosphine)ruthenium(II) chloride(9.0 mg, 0.01 mmol), potassium t-butoxide (115.4 mg, 1.03 mmol),Mixing in 1,4-dioxane (4 mL), stirring in a 120 ° C oil bath for 22 hours;After completion of the reaction, methanol and dichloromethane were added thereto, and the mixture was filtered, and the filtrate was concentrated.The eluate having an Rf value of 0.3 to 0.35 is collected, distilled under reduced pressure, and dried to obtain the target compound (II-1).95.2 mg, the yield was 67percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
42% | With acetic acid; at 120℃; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride, metformin hydrochloride or phenformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120°C for 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
42% | With acetic acid; at 120℃; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride, metformin hydrochloride or phenformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120°C for 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
48% | With acetic acid; at 120℃; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride, metformin hydrochloride or phenformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120°C for 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
52% | With acetic acid; at 120℃; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride, metformin hydrochloride or phenformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120°C for 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
52% | With acetic acid; at 120℃; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride, metformin hydrochloride or phenformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120°C for 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
52% | With acetic acid; at 120℃; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride, metformin hydrochloride or phenformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120°C for 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
52% | With acetic acid; at 120℃; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride, metformin hydrochloride or phenformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120°C for 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
45% | With acetic acid; at 120℃; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride, metformin hydrochloride or phenformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120°C for 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
45% | With acetic acid; at 120℃; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride, metformin hydrochloride or phenformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120°C for 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
45% | With acetic acid; at 120℃; | General procedure: Synthesized intermediate compounds (1 mmol) and Moroxydine hydrochloride, metformin hydrochloride or phenformin hydrochloride (1 mmol) were refluxed in glacial acetic acid (10 mL) at 120°C for 4?6 h. The whole processes of the reactions were traced by TLC, then removed solvent under reduced pressure. The crude products were purified by column chromatography (dichloromethane : methanol = 20 : 1). |
Tags: 3160-91-6 synthesis path| 3160-91-6 SDS| 3160-91-6 COA| 3160-91-6 purity| 3160-91-6 application| 3160-91-6 NMR| 3160-91-6 COA| 3160-91-6 structure
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :